Incidence and relevance of secondary chromosome abnormalities in childhood TEL/AML1+ acute lymphoblastic leukemia: an interphase FISH analysis
- 9 September 2004
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 18 (10) , 1611-1616
- https://doi.org/10.1038/sj.leu.2403471
Abstract
The aim of the present study was to determine the frequency and clinical relevance of the most common secondary karyotype abnormalities in TEL/AML1+ B-cell precursor acute lymphoblastic leukemia (ALL) as assessed with fluorescence in situ hybridization (FISH) analyses. Screening of 372 patients who were enrolled in two consecutive Austrian childhood ALL multicenter trials identified 94 (25%) TEL/AML1+ cases. TEL deletions, trisomy 21 and an additional der(21)t(12;21) were detected in 52 (55%), 13 (14%) and 14 (15%) TEL/AML1+ patients, respectively. The 12p aberrations (P=0.001) and near tetraploidy (P=0.045) were more common in TEL/AML1+ patients, whereas the incidence of diploidy, pseudodiploidy, hypodiploidy, low hyperdiploidy, near triploidy, del(6q), chromosome 9 and 11q23 abnormalities was similar among TEL/AML1+ and TEL/AML1- patients. None of the TEL/AML1+ patients had a high hyperdiploid karyotype. Univariate analysis indicated that among TEL/AML1+ patients those with a deletion of the nontranslocated TEL allele had a worse prognosis than those without this abnormality (P=0.034). We concluded that the type and incidence of the most common secondary aberrations in TEL/AML1+ ALL can be conveniently identified with little additional effort during interphase screening with appropriate TEL and AML1 FISH probes. We also provided preliminary evidence that the deletion of the nontranslocated TEL allele may adversely influence the clinical course of TEL/AML1+ ALL.Keywords
This publication has 40 references indexed in Scilit:
- Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemiaCancer, 2002
- Expression of TEL-AML1 Fusion Transcripts and Response to Induction Therapy in Standard Risk Acute Lymphoblastic LeukemiaLeukemia & Lymphoma, 2001
- TEL/AML-1 fusion geneCancer Genetics and Cytogenetics, 2000
- The TEL-AML1 Fusion Accompanied by Loss of the Untranslocated TEL Allele in B-Precursor Acute Lymphoblastic Leukaemia of ChildhoodLeukemia & Lymphoma, 2000
- TEL/AML1 positivity in childhood ALL: average or better prognosis?Leukemia, 1999
- Detection of the Der (21)t(12;21) Chromosome Forming theTEL-AML1Fusion Gene in Childhood Acute Lymphoblastic LeukemiaLeukemia & Lymphoma, 1997
- Correlation between theETV6/CBFA2 (TEL/AMLI) fusion gene and karyotypic abnormalities in children with B-cell precursor acute lymphoblastic leukemiaGenes, Chromosomes and Cancer, 1996
- Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.Proceedings of the National Academy of Sciences, 1995
- t( 12;21): A new recurrent translocation in acute lymphoblastic leukemiaGenes, Chromosomes and Cancer, 1994
- Minimal requirements for the diagnosis, classification, and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the “BFM family” cooperative groupMedical and Pediatric Oncology, 1992